H.R.8399 - End Taxpayer Subsidies for Drug Ads Act116th Congress (2019-2020)
|Sponsor:||Rep. Finkenauer, Abby [D-IA-1] (Introduced 09/25/2020)|
|Committees:||House - Ways and Means|
|Latest Action:||House - 09/25/2020 Referred to the House Committee on Ways and Means. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.8399 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (09/25/2020)
End Taxpayer Subsidies for Drug Ads Act
This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.
Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.